| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | methylnaltrexone bromide (Relistor®) |
| Formulation | 12 mg/0.6 ml solution for injection |
| Reference number | 201 |
| Indication | Treatment of opioid-induced constipation in advanced illness patients who are receiving palliative care when response to usual laxative therapy has not been sufficient |
| Company | TMC Pharma Services Ltd |
| BNF chapter | Gastro-intestinal system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 13/08/2008 |